title: Serotonergic dystrophy induced by excess serotonin.
abstract: Administration of certain serotonin-releasing amphetamine derivatives (fenfluramine and/or 3,4-methylenedioxymethamphetamine, MDMA, 'ecstasy') results in dystrophic serotonergic morphology in the mammalian brain. In addition to drug administration, dystrophic serotonergic neurites are also associated with neurodegenerative disorders. We demonstrate here that endogenously elevated serotonin in the Drosophila CNS induces aberrant enlarged varicosities, or spheroids, that are morphologically similar to dystrophic mammalian serotonergic fibers. In Drosophila these spheroids are specific to serotonergic neurons, distinct from typical varicosities, and form only after prolonged increases in cytoplasmic serotonin. Our results also suggest that serotonin levels during early development determine later sensitivity of spheroid formation to manipulations of the serotonin transporter (SERT). Elevated serotonin also interacts with canonical protein aggregation and autophagic pathways to form spheroids. The data presented here support a model in which excess cytoplasmic neurotransmitter triggers a cell-specific pathway inducing aberrant morphology in fly serotonergic neurons that may be shared in certain mammalian pathologies.
authors.affiliation: Neuroscience Graduate Program, University of Virginia, Charlottesville, VA 22908, USA.
authors.forename: Elizabeth A
authors.initials: EA
authors.lastname: Daubert
authors.forename: Daniel S
authors.initials: DS
authors.lastname: Heffron
authors.forename: James W
authors.initials: JW
authors.lastname: Mandell
authors.forename: Barry G
authors.initials: BG
authors.lastname: Condron
mesh_terms: D000818:Animals; D001369:Axons / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure*; D001921:Brain / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D004331:Drosophila melanogaster / Q000033:anatomy & histology / Q000187:drug effects / Q000378:metabolism*; D005277:Fenfluramine / Q000494:pharmacology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000494:pharmacology; D009474:Neurons / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure*; D012701:Serotonin / Q000378:metabolism* / Q000494:pharmacology; D018490:Serotonin Agents / Q000378:metabolism / Q000494:pharmacology*; D019076:Transgenes
chemical_list: D018490:Serotonin Agents; D005277:Fenfluramine; D012701:Serotonin; D018817:N-Methyl-3,4-methylenedioxyamphetamine
references.citation: J Neurosci. 1988 Aug;8(8):2788-803
references.pmid: 2457659
references.citation: J Pharmacol Exp Ther. 1989 Jun;249(3):928-43
references.pmid: 2732954
references.citation: J Neurosci. 2004 Apr 21;24(16):3899-906
references.pmid: 15102905
references.citation: Pharmacol Ther. 2009 Jan;121(1):89-99
references.pmid: 19022290
references.citation: Neuron. 2003 Jun 19;38(6):871-85
references.pmid: 12818174
references.citation: Science. 2001 Jul 27;293(5530):711-4
references.pmid: 11408621
references.citation: Lancet Neurol. 2007 Apr;6(4):352-61
references.pmid: 17362839
references.citation: Brain Res. 1990 Mar 12;511(1):165-8
references.pmid: 2331614
references.citation: J Neurosci. 1998 Jul 1;18(13):4854-60
references.pmid: 9634551
references.citation: Biol Psychiatry. 2003 Nov 15;54(10):953-9
references.pmid: 14625137
references.citation: J Neurosci. 2006 Aug 2;26(31):8057-68
references.pmid: 16885219
references.citation: Dev Biol. 1995 Jan;167(1):282-93
references.pmid: 7851649
references.citation: Nat Rev Neurosci. 2008 Nov;9(11):826-38
references.pmid: 18931696
references.citation: Eur J Neurosci. 2007 Jul;26(2):424-38
references.pmid: 17650115
references.citation: Dev Biol. 2005 Oct 1;286(1):207-16
references.pmid: 16122730
references.citation: Br J Pharmacol. 2001 Sep;134(1):46-57
references.pmid: 11522596
references.citation: Genes Brain Behav. 2007 Nov;6(8):756-69
references.pmid: 17376153
references.citation: Neurosci Lett. 1986 Jun 30;67(3):307-12
references.pmid: 3461314
references.citation: Mol Pharmacol. 2001 Jan;59(1):83-95
references.pmid: 11125028
references.citation: Mol Pharmacol. 1993 Dec;44(6):1227-31
references.pmid: 7903417
references.citation: Proc Natl Acad Sci U S A. 2003 May 13;100(10):5950-5
references.pmid: 12730384
references.citation: J Neurochem. 2008 Aug;106(3):1426-39
references.pmid: 18489716
references.citation: Cell. 2003 Dec 26;115(7):851-62
references.pmid: 14697203
references.citation: J Neurosci. 2002 Oct 15;22(20):8942-50
references.pmid: 12388601
references.citation: CSH Protoc. 2007 Jun 01;2007:pdb.prot4771
references.pmid: 21357109
references.citation: J Neurosci Methods. 2009 May 15;179(2):300-8
references.pmid: 19428541
references.citation: Dev Biol. 2008 Aug 1;320(1):30-8
references.pmid: 18561908
references.citation: Ann N Y Acad Sci. 1990;600:649-61; discussion 661-4
references.pmid: 1979216
references.citation: Hum Mol Genet. 2006 Feb 1;15(3):433-42
references.pmid: 16368705
references.citation: Hum Mol Genet. 2008 Jan 15;17(2):170-8
references.pmid: 17921520
references.citation: Nat Cell Biol. 2003 Jun;5(6):566-71
references.pmid: 12766776
references.citation: Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1817-21
references.pmid: 1347426
references.citation: Mol Psychiatry. 2005 Aug;10(8):782-9, 714
references.pmid: 15940298
references.citation: Neuron. 2003 Jul 17;39(2):217-25
references.pmid: 12873380
references.citation: Brain Res. 2008 Jun 27;1217:185-94
references.pmid: 18502405
references.citation: Cell. 2000 Mar 31;101(1):57-66
references.pmid: 10778856
references.citation: Arch Insect Biochem Physiol. 2005 May;59(1):12-31
references.pmid: 15822093
references.citation: J Neurosci. 1989 Aug;9(8):2866-77
references.pmid: 2570137
references.citation: Proc Natl Acad Sci U S A. 2005 Mar 8;102(10):3777-81
references.pmid: 15716359
references.citation: J Neurosci. 2008 Dec 17;28(51):13805-14
references.pmid: 19091971
references.citation: Am J Pathol. 2007 Aug;171(2):513-24
references.pmid: 17620365
references.citation: Mol Psychiatry. 2006 Jan;11(1):99-113
references.pmid: 16189511
references.citation: Dev Dyn. 2008 Aug;237(8):2090-9
references.pmid: 18627097
references.citation: J Pharmacol Exp Ther. 2008 Jul;326(1):153-62
references.pmid: 18400843
references.citation: J Comp Neurol. 2009 Aug 1;515(4):441-53
references.pmid: 19459220
references.citation: Neurochem Res. 2006 Dec;31(12):1425-32
references.pmid: 17086442
references.citation: J Clin Invest. 2007 Jan;117(1):236-45
references.pmid: 17173140
references.citation: Nat Genet. 2007 May;39(5):678-82
references.pmid: 17450142
references.citation: Dev Cell. 2004 Aug;7(2):179-92
references.pmid: 15296715
references.citation: Curr Biol. 2006 Jun 6;16(11):1051-62
references.pmid: 16753559
references.citation: Science. 2004 Oct 29;306(5697):879-81
references.pmid: 15514160
references.citation: J Biol Chem. 2007 Feb 2;282(5):2918-28
references.pmid: 17142836
references.citation: J Comp Neurol. 1988 Feb 15;268(3):414-28
references.pmid: 3129459
references.citation: Curr Biol. 2007 Jan 9;17(1):1-11
references.pmid: 17208179
references.citation: Eur J Pharmacol. 2008 May 13;585(2-3):464-72
references.pmid: 18417122
references.citation: J Neurobiol. 2003 Mar;54(4):618-27
references.pmid: 12555273
references.citation: Synapse. 1998 Sep;30(1):62-70
references.pmid: 9704882
references.citation: J Neurochem. 2003 Oct;87(1):268-71
references.pmid: 12969273
references.citation: Curr Biol. 1999 Dec 2;9(23):1382-91
references.pmid: 10607562
references.citation: Neuron. 2009 Apr 30;62(2):218-29
references.pmid: 19409267